Free Trial

Captrust Financial Advisors Lowers Position in Exponent, Inc. (NASDAQ:EXPO)

Exponent logo with Business Services background

Captrust Financial Advisors decreased its holdings in shares of Exponent, Inc. (NASDAQ:EXPO - Free Report) by 14.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 20,628 shares of the business services provider's stock after selling 3,523 shares during the quarter. Captrust Financial Advisors' holdings in Exponent were worth $1,838,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of the business. Barclays PLC increased its position in Exponent by 219.0% in the third quarter. Barclays PLC now owns 96,526 shares of the business services provider's stock worth $11,127,000 after purchasing an additional 66,263 shares during the period. Argent Capital Management LLC raised its position in shares of Exponent by 17.3% during the fourth quarter. Argent Capital Management LLC now owns 28,323 shares of the business services provider's stock worth $2,524,000 after purchasing an additional 4,173 shares during the period. Heritage Family Offices LLP raised its position in shares of Exponent by 3.8% during the fourth quarter. Heritage Family Offices LLP now owns 3,123 shares of the business services provider's stock worth $278,000 after purchasing an additional 114 shares during the period. Empirical Asset Management LLC acquired a new stake in shares of Exponent during the fourth quarter worth about $234,000. Finally, Trust Co. of Vermont acquired a new stake in Exponent in the 4th quarter valued at approximately $45,000. Institutional investors and hedge funds own 92.37% of the company's stock.

Insider Buying and Selling at Exponent

In other Exponent news, VP Richard Reiss sold 1,736 shares of the stock in a transaction that occurred on Wednesday, February 26th. The shares were sold at an average price of $85.93, for a total value of $149,174.48. Following the sale, the vice president now directly owns 1,800 shares in the company, valued at $154,674. This represents a 49.10% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 2.10% of the company's stock.

Exponent Price Performance

EXPO stock traded up $0.82 during mid-day trading on Friday, reaching $80.05. The company had a trading volume of 458,574 shares, compared to its average volume of 244,979. The stock has a 50 day simple moving average of $79.27 and a two-hundred day simple moving average of $87.74. The company has a market capitalization of $4.06 billion, a price-to-earnings ratio of 37.76 and a beta of 0.95. Exponent, Inc. has a 52 week low of $73.37 and a 52 week high of $115.75.

Exponent (NASDAQ:EXPO - Get Free Report) last issued its quarterly earnings data on Thursday, May 1st. The business services provider reported $0.52 EPS for the quarter, beating analysts' consensus estimates of $0.48 by $0.04. Exponent had a return on equity of 27.27% and a net margin of 19.52%. The firm had revenue of $137.44 million for the quarter, compared to analyst estimates of $134.63 million. During the same period in the prior year, the firm posted $0.59 EPS. The company's revenue for the quarter was up .2% on a year-over-year basis. On average, equities analysts predict that Exponent, Inc. will post 1.98 EPS for the current year.

Exponent Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, June 20th. Investors of record on Friday, June 6th will be paid a $0.30 dividend. The ex-dividend date is Friday, June 6th. This represents a $1.20 annualized dividend and a dividend yield of 1.50%. Exponent's dividend payout ratio is 58.54%.

About Exponent

(Free Report)

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.

Featured Stories

Institutional Ownership by Quarter for Exponent (NASDAQ:EXPO)

Should You Invest $1,000 in Exponent Right Now?

Before you consider Exponent, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.

While Exponent currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Top 3 Defense Stocks to Profit From $175 Billion Golden Dome
Top 5 Stocks for June: AI Picks That Aren’t NVIDIA
This Unique Robotaxi Play Could Deliver 10X Returns

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines